Key result
Inflammation plays a key role in the onset and progression of heart failure after myocardial infarction, and targeting inflammatory pathways provides a theoretical basis for prevention and treatment.
Why the study?
Inflammation plays a key role in the onset and progression of heart failure after myocardial infarction, but the mechanisms and therapeutic strategies require summarization.
Answers are grounded in this paper and cite their sources.
This review highlights the critical role of inflammatory mechanisms in the development of heart failure after myocardial infarction and underscores the therapeutic potential of targeting these pathways with agents like colchicine and SGLT2 inhibitors.
Inflammation plays a key role in the onset and progression of heart failure (HF) after myocardial infarction (MI), which represents one of the leading causes of mortality in patients with cardiovascular disease. This review summarizes the inflammatory mechanisms involved at different stages of HF after MI, including the infiltration and activation of inflammatory cells, the release of inflammatory mediators, and the effects of these mediators on cardiomyocytes, the extracellular matrix, and cardiac function. In addition, this review discusses therapeutic strategies that target inflammatory pathways, providing a theoretical basis for the prevention and treatment of HF after MI.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a review in Heart failure after myocardial infarction. Anti-inflammatory therapies was evaluated. Inflammation plays a key role in the onset and progression of heart failure after myocardial infarction, and targeting inflammatory pathways provides a theoretical basis for prevention and treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: